Valeant Pharmaceuticals International Inc. agreed to acquire Salix Pharmaceuticals Ltd. for $158.00 per share, or a total enterprise value of $14.5 billion, the two companies said on Sunday. The transaction, ...
via Business News http://ift.tt/1D0lWLL
0 commentaires:
Enregistrer un commentaire